Current practices of Asia-Pacific cardiologists in the utilization of bioresorbable scaffolds

Autor: Sudheer Saxena, Ashok Seth, Jack Jun Cheng, Hyeon Cheol Gwon, S. Mathew, Teguh Santoso, G. Sengottuvelu, On Hing Kwok, Chee Siong Soo, Cheng Ting Tsai, Tiemin Jiang, Shubin Qiao, Krishnankutty Sudhir, Dougal McClean, Praveen Chandra, Adrian F. Low, Carl Schultz, Yee Guan Yap, Rony Mathew, Anuruck Jeamanukoolkit, Christopher X. Wong, Charles A. Simonton, B. B. Chanana, Michael Nguyen, Sunao Nakamura, M.S. Hiremath, Do Quang Huan, Michael C L Lim, Ronald Dick, Udayachalerm Wasan, Alan Whelan
Rok vydání: 2016
Předmět:
Zdroj: International Journal of Cardiology. 222:832-840
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2016.07.273
Popis: Background & aims Although Absorb Bioresorbable Vascular Scaffolds (A-BVS) are routinely used in the Asia-Pacific, there is little information on patient selection or deployment technique here. This document investigates the experiences of leading interventional cardiologists from the Asia-Pacific region with a focus on patient characteristics, deployment techniques and management. Methods and results A detailed questionnaire was distributed to 28 highly-experienced interventional cardiologists (‘Authors') from 13 Asia-Pacific countries. The results were discussed at a meeting on patient selection, technical consideration, deployment practices and patient management. Potential patient benefits of Absorb compared to metallic DES, the learning curve for patient selection and preparation, device deployment, and subsequent patient management approaches are presented. Conclusions Current practices are derived from guidelines optimized for European patients. Differences in approach exist in the Asia-Pacific context, including limited access to imaging and frequency of occurrence of complex lesions. Nevertheless, the use of the Absorb BVS (‘Absorb') in certain Asia-Pacific countries has flourished and practices here are continuing to mature.
Databáze: OpenAIRE